ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer

By sjmartinez • June 28, 2024

Qian C, Yang Q, Rotinen M, Huang R, Kim H, Gallent B, Yan Y, Cadaneanu RM, Zhang B, Kaochar S, Freedland SJ, Posadas EM, Ellis L, Di Vizio D, Morrissey C, Nelson PS, Brady L, Murali R, Campbell MJ, Yang W, Knudsen BS, Mostaghel EA, Ye H, Garraway IP, You S, Freeman MR. ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer. Nucleic Acids Res. 2024 Jun 27:gkae547. doi: 10.1093/nar/gkae547. Epub ahead of print. PMID: 38932701.

Tags: Cedars Sinai DoM, General Internal Medicine, Publications

Related Posts

Early U.S. Commercial Experience With a Novel Transcatheter Edge-to-Edge Repair System: Insights From Real-World Data

Waggoner T, Garcia S, Chakravarty T, Makar M, Latib A, Kipperman RM, Zahr F, Hanson I, Sinha AK, Sharma RP, Depta JP, Castellanos JA, Kodali[...]

Prediction of Immunotherapy Response in Hepatocellular Carcinoma Patients Using Pretreatment CT Images

Min JH, Chen PJ, Qureshi TA, Javed S, Xie Y, Azab L, Wang L, Kim HS, Li D, Yang JD. Prediction of Immunotherapy Response in[...]

Improved Myocardial Tissue Characterization Using Delayed-Phase Dynamic Contrast-enhanced Cardiac MRI

Huang LT, Zhang X, Li X, Malagi A, Huang Y, Guan X, Ho H, Kwan A, Wei J, Bi X, Christodoulou AG, Li D, Han[...]